Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tidewater Inc. (TDW)’s Stock Drops on Disappointing Financial Results

Page 1 of 2

 Tidewater Inc. (NYSE:TDW)’s shares are trading more than 30% lower on the back of a disappointing fiscal fourth-quarter earnings report. For the three months ended March 31, the company posted a loss of $1.74 per common share on revenue of $184.2 million, versus a loss of $0.19 per share on sales of $324.8 million reported a year earlier. For the full fiscal year, the company reported a loss of $3.41 per common share on sales of $979.1 million, versus the previous fiscal year’s loss of $1.34 per share on sales of $1.496 billion. One reason for wider losses is that Tidewater took a $0.87 per share non-cash asset impairment charge during the fourth quarter. The company also registered a $0.18 per share foreign exchange loss related to its Angola joint venture, Sonatide. Tidewater’s internal forecast indicates that, within fiscal 2017, the company may no longer be in compliance with the minimum interest coverage ratio requirement of 3.0x that the company has with banks. In connection with this development, the company said:

“We expect the report of the company’s independent registered public accounting firm that accompanies our audited consolidated financial statements for the fiscal year ended March 31, 2016 (the “audit opinion”) will contain an explanatory paragraph regarding our ability to continue as a going concern.”

However, Tidewater is engaged in discussions with its principal noteholders and lenders to amend the company’s 3.0x minimum interest coverage ratio covenant in advance of any potential default occurring.

Follow Tidewater Inc (NYSE:TDW)
Trade (NYSE:TDW) Now!

According to most stock holders, hedge funds are assumed to be underperforming, outdated investment vehicles of yesteryear. While there are greater than 8000 funds with their doors open at present, Our experts look at the top tier of this group, approximately 700 funds. These investment experts control bulk of the smart money’s total asset base, and by keeping track of their best investments, Insider Monkey has spotted various investment strategies that have historically surpassed the broader indices. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, let’s go over the new action surrounding Tidewater Inc. (NYSE:TDW).

At the end of the first quarter, a total of 13 of the hedge funds tracked by Insider Monkey were long this stock, down by one from one quarter earlier. With hedgies’ sentiment swirling, there exists a few noteworthy hedge fund managers who were upping their holdings significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Jim Simons’ Renaissance Technologies holds the largest position in Tidewater Inc. (NYSE:TDW). Renaissance Technologies has a $13 million position in the stock, comprising less than 0.1% of its 13F portfolio. Coming in second is East Side Capital (RR Partners), led by Steven Richman, holding a $8.1 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Some other peers that are bullish comprise D. E. Shaw’s D E Shaw, Israel Englander’s Millennium Management and Matthew Hulsizer’s PEAK6 Capital Management.

On the next page, we are going to take a look at some funds that decided to exit the stock during the first quarter. In addition, at the end of this article we will also compare TDW to other stocks including Culp, Inc. (NYSE:CFI), Eclipse Resources Corp (NYSE:ECR), and Cardionet Inc (NASDAQ:BEAT) to get a better sense of its popularity.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!